NICKSON PHILIP (General Counsel) sold 4.9% of their position (3.15K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $47.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2026ACC: 0001193125-26-002406
Officer· General Counsel
Since Mar 2022
+150.84K
Net shares
Net buyer
$47.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
154K acquired · 3.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28K
Price / share
—
Trade value
—
% of position
77.8%
1/2/2026
36K→64K
Common Stock
Direct
Shares
−3.15K
Price / share
$15.17
Trade value
$47.86K
% of position
4.9%
1/5/2026
64K→60.84K
Total
Net shares
+24.84K
Net value
-$47.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +28K | — | — | 77.8% | 36K | 64K |
| Common Stock Direct | 1/5/2026 | S · Sale | −3.15K | $15.17 | $47.86K | 4.9% | 64K | 60.84K |
| Total | +24.84K | -$47.86K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
126K shares
Shares
+126K
Strike price
15.31
Held after
126K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock126K shares | 1/2/2026 | A · Award | +126K | 15.31 | — | 126K |